Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
de Hemptinne
B
B
Department of Surgery, University of Louvain Medical School, Brussels, Belgium.
Lamy
M E
ME
Salizzoni
M
M
Cornu
C
C
Mostin
J
J
Fevery
J
J
De Groote
V
V
Otte
J B
JB
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000635:transmission; D004341:Drug Evaluation; D015774:Ganciclovir / Q000031:analogs & derivatives*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016031:Liver Transplantation; D011183:Postoperative Complications / Q000188:drug therapy*; D014775:Virus Activation
D000914:Antibodies, Viral; D000998:Antiviral Agents; C045895:9-((2,3-dihydroxy-1-propoxy)methyl)guanine; D015774:Ganciclovir; D000212:Acyclovir